![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MARVELD3 |
Gene summary for MARVELD3 |
![]() |
Gene information | Species | Human | Gene symbol | MARVELD3 | Gene ID | 91862 |
Gene name | MARVEL domain containing 3 | |
Gene Alias | MARVD3 | |
Cytomap | 16q22.2 | |
Gene Type | protein-coding | GO ID | GO:0000165 | UniProtAcc | Q96A59 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
91862 | MARVELD3 | HTA11_2487_2000001011 | Human | Colorectum | SER | 4.17e-08 | 6.34e-01 | -0.1808 |
91862 | MARVELD3 | HTA11_78_2000001011 | Human | Colorectum | AD | 3.39e-02 | 3.80e-01 | -0.1088 |
91862 | MARVELD3 | HTA11_347_2000001011 | Human | Colorectum | AD | 4.86e-15 | 6.60e-01 | -0.1954 |
91862 | MARVELD3 | A002-C-010 | Human | Colorectum | FAP | 3.05e-04 | -1.88e-01 | 0.242 |
91862 | MARVELD3 | A001-C-207 | Human | Colorectum | FAP | 7.54e-03 | -2.45e-01 | 0.1278 |
91862 | MARVELD3 | A015-C-203 | Human | Colorectum | FAP | 3.23e-10 | -2.12e-01 | -0.1294 |
91862 | MARVELD3 | A002-C-201 | Human | Colorectum | FAP | 4.80e-05 | -2.27e-01 | 0.0324 |
91862 | MARVELD3 | A002-C-203 | Human | Colorectum | FAP | 1.66e-04 | -1.98e-01 | 0.2786 |
91862 | MARVELD3 | A001-C-119 | Human | Colorectum | FAP | 2.73e-06 | -3.56e-01 | -0.1557 |
91862 | MARVELD3 | A001-C-108 | Human | Colorectum | FAP | 1.41e-09 | -2.47e-01 | -0.0272 |
91862 | MARVELD3 | A002-C-205 | Human | Colorectum | FAP | 7.04e-10 | -3.01e-01 | -0.1236 |
91862 | MARVELD3 | A001-C-104 | Human | Colorectum | FAP | 4.77e-06 | -2.47e-01 | 0.0184 |
91862 | MARVELD3 | A015-C-006 | Human | Colorectum | FAP | 4.48e-05 | -2.95e-01 | -0.0994 |
91862 | MARVELD3 | A015-C-106 | Human | Colorectum | FAP | 1.27e-06 | -2.16e-01 | -0.0511 |
91862 | MARVELD3 | A002-C-114 | Human | Colorectum | FAP | 4.58e-07 | -2.90e-01 | -0.1561 |
91862 | MARVELD3 | A015-C-104 | Human | Colorectum | FAP | 1.76e-11 | -2.48e-01 | -0.1899 |
91862 | MARVELD3 | A001-C-014 | Human | Colorectum | FAP | 8.79e-06 | -2.29e-01 | 0.0135 |
91862 | MARVELD3 | A002-C-016 | Human | Colorectum | FAP | 5.18e-10 | -3.00e-01 | 0.0521 |
91862 | MARVELD3 | A015-C-002 | Human | Colorectum | FAP | 1.92e-04 | -2.92e-01 | -0.0763 |
91862 | MARVELD3 | A001-C-203 | Human | Colorectum | FAP | 4.20e-08 | -2.26e-01 | -0.0481 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0045216 | Colorectum | AD | cell-cell junction organization | 80/3918 | 200/18723 | 5.57e-10 | 4.58e-08 | 80 |
GO:0034329 | Colorectum | AD | cell junction assembly | 136/3918 | 420/18723 | 2.02e-08 | 1.15e-06 | 136 |
GO:0007043 | Colorectum | AD | cell-cell junction assembly | 57/3918 | 146/18723 | 4.18e-07 | 1.61e-05 | 57 |
GO:0043297 | Colorectum | AD | apical junction assembly | 34/3918 | 78/18723 | 5.31e-06 | 1.37e-04 | 34 |
GO:0001667 | Colorectum | AD | ameboidal-type cell migration | 137/3918 | 475/18723 | 2.17e-05 | 4.33e-04 | 137 |
GO:0120193 | Colorectum | AD | tight junction organization | 33/3918 | 80/18723 | 2.93e-05 | 5.42e-04 | 33 |
GO:0120192 | Colorectum | AD | tight junction assembly | 31/3918 | 74/18723 | 3.53e-05 | 6.43e-04 | 31 |
GO:0090132 | Colorectum | AD | epithelium migration | 105/3918 | 360/18723 | 1.18e-04 | 1.73e-03 | 105 |
GO:0010632 | Colorectum | AD | regulation of epithelial cell migration | 88/3918 | 292/18723 | 1.19e-04 | 1.75e-03 | 88 |
GO:0010631 | Colorectum | AD | epithelial cell migration | 104/3918 | 357/18723 | 1.33e-04 | 1.90e-03 | 104 |
GO:0090130 | Colorectum | AD | tissue migration | 105/3918 | 365/18723 | 2.10e-04 | 2.77e-03 | 105 |
GO:0070830 | Colorectum | AD | bicellular tight junction assembly | 28/3918 | 70/18723 | 2.15e-04 | 2.83e-03 | 28 |
GO:0043409 | Colorectum | AD | negative regulation of MAPK cascade | 57/3918 | 180/18723 | 4.61e-04 | 5.14e-03 | 57 |
GO:0051403 | Colorectum | AD | stress-activated MAPK cascade | 72/3918 | 239/18723 | 4.77e-04 | 5.25e-03 | 72 |
GO:0031098 | Colorectum | AD | stress-activated protein kinase signaling cascade | 74/3918 | 247/18723 | 4.80e-04 | 5.27e-03 | 74 |
GO:0050673 | Colorectum | AD | epithelial cell proliferation | 119/3918 | 437/18723 | 8.75e-04 | 8.51e-03 | 119 |
GO:0070302 | Colorectum | AD | regulation of stress-activated protein kinase signaling cascade | 58/3918 | 195/18723 | 2.21e-03 | 1.74e-02 | 58 |
GO:0032872 | Colorectum | AD | regulation of stress-activated MAPK cascade | 57/3918 | 192/18723 | 2.51e-03 | 1.92e-02 | 57 |
GO:1902414 | Colorectum | AD | protein localization to cell junction | 31/3918 | 94/18723 | 4.30e-03 | 2.95e-02 | 31 |
GO:0032873 | Colorectum | AD | negative regulation of stress-activated MAPK cascade | 19/3918 | 51/18723 | 5.44e-03 | 3.55e-02 | 19 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa04530 | Colorectum | AD | Tight junction | 76/2092 | 169/8465 | 5.49e-09 | 9.69e-08 | 6.18e-08 | 76 |
hsa045301 | Colorectum | AD | Tight junction | 76/2092 | 169/8465 | 5.49e-09 | 9.69e-08 | 6.18e-08 | 76 |
hsa045302 | Colorectum | SER | Tight junction | 59/1580 | 169/8465 | 3.24e-07 | 5.98e-06 | 4.34e-06 | 59 |
hsa045303 | Colorectum | SER | Tight junction | 59/1580 | 169/8465 | 3.24e-07 | 5.98e-06 | 4.34e-06 | 59 |
hsa045308 | Colorectum | FAP | Tight junction | 60/1404 | 169/8465 | 1.40e-09 | 9.33e-08 | 5.67e-08 | 60 |
hsa045309 | Colorectum | FAP | Tight junction | 60/1404 | 169/8465 | 1.40e-09 | 9.33e-08 | 5.67e-08 | 60 |
hsa0453010 | Colorectum | CRC | Tight junction | 44/1091 | 169/8465 | 2.51e-06 | 7.61e-05 | 5.16e-05 | 44 |
hsa0453011 | Colorectum | CRC | Tight junction | 44/1091 | 169/8465 | 2.51e-06 | 7.61e-05 | 5.16e-05 | 44 |
hsa04530211 | Esophagus | ESCC | Tight junction | 105/4205 | 169/8465 | 6.73e-04 | 2.23e-03 | 1.14e-03 | 105 |
hsa04530310 | Esophagus | ESCC | Tight junction | 105/4205 | 169/8465 | 6.73e-04 | 2.23e-03 | 1.14e-03 | 105 |
hsa0453022 | Liver | Cirrhotic | Tight junction | 82/2530 | 169/8465 | 2.14e-07 | 2.85e-06 | 1.76e-06 | 82 |
hsa0453032 | Liver | Cirrhotic | Tight junction | 82/2530 | 169/8465 | 2.14e-07 | 2.85e-06 | 1.76e-06 | 82 |
hsa0453042 | Liver | HCC | Tight junction | 110/4020 | 169/8465 | 2.45e-06 | 2.28e-05 | 1.27e-05 | 110 |
hsa0453052 | Liver | HCC | Tight junction | 110/4020 | 169/8465 | 2.45e-06 | 2.28e-05 | 1.27e-05 | 110 |
hsa0453030 | Oral cavity | OSCC | Tight junction | 102/3704 | 169/8465 | 8.68e-06 | 3.93e-05 | 2.00e-05 | 102 |
hsa04530114 | Oral cavity | OSCC | Tight junction | 102/3704 | 169/8465 | 8.68e-06 | 3.93e-05 | 2.00e-05 | 102 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MARVELD3 | SNV | Missense_Mutation | c.1165N>G | p.Lys389Glu | p.K389E | Q96A59 | protein_coding | deleterious(0) | benign(0.011) | TCGA-18-3406-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
MARVELD3 | SNV | Missense_Mutation | novel | c.748N>A | p.Glu250Lys | p.E250K | Q96A59 | protein_coding | deleterious(0.04) | possibly_damaging(0.793) | TCGA-63-A5MS-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
MARVELD3 | SNV | Missense_Mutation | c.1226N>G | p.Thr409Ser | p.T409S | Q96A59 | protein_coding | deleterious_low_confidence(0.01) | possibly_damaging(0.616) | TCGA-66-2766-01 | Lung | lung squamous cell carcinoma | Male | <65 | III/IV | Unknown | Unknown | SD | |
MARVELD3 | SNV | Missense_Mutation | novel | c.932N>T | p.Ala311Val | p.A311V | Q96A59 | protein_coding | deleterious(0.01) | possibly_damaging(0.9) | TCGA-NK-A5D1-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | gemcitabine | PD |
MARVELD3 | SNV | Missense_Mutation | novel | c.1014N>C | p.Glu338Asp | p.E338D | Q96A59 | protein_coding | deleterious(0.01) | probably_damaging(0.921) | TCGA-BB-8596-01 | Oral cavity | head & neck squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MARVELD3 | SNV | Missense_Mutation | novel | c.787C>A | p.Arg263Ser | p.R263S | Q96A59 | protein_coding | deleterious(0) | probably_damaging(0.969) | TCGA-CN-6997-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | cisplatin | PD |
MARVELD3 | SNV | Missense_Mutation | novel | c.911N>T | p.Ala304Val | p.A304V | Q96A59 | protein_coding | deleterious(0.04) | possibly_damaging(0.618) | TCGA-D6-6516-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
MARVELD3 | SNV | Missense_Mutation | c.578N>G | p.Tyr193Cys | p.Y193C | Q96A59 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-BR-6452-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MARVELD3 | SNV | Missense_Mutation | rs376389459 | c.728C>T | p.Pro243Leu | p.P243L | Q96A59 | protein_coding | tolerated(0.06) | probably_damaging(0.975) | TCGA-F1-6177-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
MARVELD3 | SNV | Missense_Mutation | novel | c.1012N>A | p.Glu338Lys | p.E338K | Q96A59 | protein_coding | deleterious(0) | probably_damaging(0.933) | TCGA-VQ-A8E2-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | fluorouracil | CR |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |